InvestSMART

Archer Materials Limited (ASX: AXE) - Announcements

- Current share price for AXE : $0.330

ASX company news and announcements for Archer Materials Limited (AXE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Archer Materials Limited (AXE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Archer Materials Limited (AXE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Archer Materials Limited (AXE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$84 AXE advances quantum strategy amid growing global momentum 15 Jun 2026 9:38AM $0.365 $0.330 fallen by 9.59%
$84 Archer QML Project achieves key milestones 4 Jun 2026 1:56PM $0.385 $0.330 fallen by 14.29%
$84 Notification of cessation of securities - AXE 21 May 2026 4:41PM $0.305 $0.330 risen by 8.20%
$84 Biosensor beta prototype and manufacturing pathway advanced 15 May 2026 9:20AM $0.320 $0.330 risen by 3.13%
$84 Archer strengthens pathway to quantum device manufacturing 12 May 2026 9:17AM $0.290 $0.330 risen by 13.79%
$84 Archer to host quarterly update investor webinar 4 May 2026 9:24AM $0.300 $0.330 risen by 10%
$84 Quarterly Activities/Appendix 4C Cash Flow Report 29 Apr 2026 9:31AM $0.280 $0.330 risen by 17.86%
$84 Notification of cessation of securities - AXE 22 Apr 2026 5:37PM $0.315 $0.330 risen by 4.76%
$84 Biochip advances toward beta prototype & clinical validation 7 Apr 2026 10:30AM $0.280 $0.330 risen by 17.86%
$84 Archer to commence QML simulations and benchmarking 18 Mar 2026 9:19AM $0.335 $0.330 fallen by 1.49%
$84 1H FY26 Update - Presentation 4 Mar 2026 9:14AM $0.355 $0.330 fallen by 7.04%
$84 Appendix 4D and Half Year Financial Report 25 Feb 2026 9:45AM $0.355 $0.330 fallen by 7.04%
$84 Quantum program advances with ecosystem-led execution 12 Feb 2026 9:30AM $0.370 $0.330 fallen by 10.81%
$84 Archer develops early Biochip prototype 30 Jan 2026 9:21AM $0.375 $0.330 fallen by 12%
$84 Investor Webinar - Presentation 29 Jan 2026 10:39AM $0.385 $0.330 fallen by 14.29%
$84 Quarterly Activities/Appendix 4C Cash Flow Report 29 Jan 2026 9:22AM $0.390 $0.330 fallen by 15.38%
$84 Archer to host quarterly update investor webinar 22 Jan 2026 8:25AM $0.395 $0.330 fallen by 16.46%
$84 Letter to Shareholders 9 Jan 2026 9:26AM $0.445 $0.330 fallen by 25.84%
$84 Final Director's Interest Notice - KW 1 Dec 2025 2:32PM $0.360 $0.330 fallen by 8.33%
$84 Initial Director's Interest Notice - AJ 1 Dec 2025 2:32PM $0.360 $0.330 fallen by 8.33%
$84 Archer Board Changes 1 Dec 2025 2:31PM $0.360 $0.330 fallen by 8.33%
$84 Change of Director's Interest Notice - GE 20 Nov 2025 6:28PM $0.385 $0.330 fallen by 14.29%
$84 Notification regarding unquoted securities - AXE 20 Nov 2025 6:26PM $0.385 $0.330 fallen by 14.29%
$84 Results of 2025 Annual General Meeting 20 Nov 2025 12:13PM $0.380 $0.330 fallen by 13.16%
$84 AGM Presentation 20 Nov 2025 10:14AM $0.370 $0.330 fallen by 10.81%

1 - 25 of 904 results

Page 1 of 37

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.